A detailed history of Keene & Associates, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Keene & Associates, Inc. holds 38,941 shares of MDT stock, worth $3.16 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares
38,941
Previous 38,814 0.33%
Holding current value
$3.16 Million
Previous $3.06 Million 14.73%
% of portfolio
2.69%
Previous 2.52%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$76.84 - $91.03 $9,758 - $11,560
127 Added 0.33%
38,941 $3.51 Million
Q2 2024

Aug 09, 2024

BUY
$78.71 - $87.02 $8,107 - $8,963
103 Added 0.27%
38,814 $3.06 Million
Q1 2024

Apr 24, 2024

SELL
$82.84 - $88.09 $17,727 - $18,851
-214 Reduced 0.55%
38,711 $3.37 Million
Q4 2023

Jan 29, 2024

SELL
$69.43 - $83.43 $25,272 - $30,368
-364 Reduced 0.93%
38,925 $3.21 Million
Q3 2023

Oct 13, 2023

BUY
$78.22 - $90.4 $15,252 - $17,628
195 Added 0.5%
39,289 $3.08 Million
Q2 2023

Jul 26, 2023

SELL
$79.47 - $91.38 $11,284 - $12,975
-142 Reduced 0.36%
39,094 $3.44 Million
Q1 2023

Apr 19, 2023

BUY
$76.72 - $87.58 $1.72 Million - $1.96 Million
22,386 Added 132.85%
39,236 $3.16 Million
Q4 2022

Feb 09, 2023

SELL
$76.18 - $87.74 $1.18 Million - $1.36 Million
-15,492 Reduced 47.9%
16,850 $1.31 Million
Q3 2022

Nov 01, 2022

BUY
$80.75 - $95.31 $109,658 - $129,430
1,358 Added 4.38%
32,342 $2.61 Million
Q2 2022

Jul 21, 2022

BUY
$87.4 - $113.09 $79,534 - $102,911
910 Added 3.03%
30,984 $2.78 Million
Q1 2022

Apr 12, 2022

BUY
$100.58 - $112.38 $3.02 Million - $3.38 Million
30,074 New
30,074 $3.34 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Keene & Associates, Inc. Portfolio

Follow Keene & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keene & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Keene & Associates, Inc. with notifications on news.